Marco Meglio, Assistant Managing Editor for NeurologyLive, has been with the team since October 2019. Follow him on Twitter @marcomeglio1 or email him at mmeglio@neurologylive.com
NeuroVoices: XinQi Dong, MD, MPH, on Assessing Evidence for Dementia Care Interventions
March 10th 2021The director of the Institute for Health, Health Care Policy and Aging Research at Rutgers University discussed a recently published report on meeting the challenge of caring for persons with dementia and their care partners and caregivers.
Inconsistencies in End Points, Study Design Identified in Migraine Treatment Trials
February 22nd 2021Investigators noted that empirical work is needed to determine if change from baseline, fixed time point assessments, and responder definitions, or other approaches optimize power and sensitivity to change.
NeuroVoices: Marwan Sabbagh, MD, on Assessing a Cancer Drug in Alzheimer Disease
February 17th 2021The director of the Lou Ruvo Center for Brain Health and neurologist at Cleveland Clinic discussed a recently initiated study that will look at the FDA-approved cancer drug lenalidomide for the treatment of Alzheimer disease.